Search - tctmd.com

Displaying 1 - 20 of 64

Sort: Relevancy | Date

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Caitlin E. Cox

March 30, 2025

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Michael O'Riordan

March 30, 2025

News Conference News ACC 2024

Telemedicine Strategy After MI Scores a Win in TELE-ACS

Caitlin E. Cox

April 12, 2024

News Conference News ACC 2024

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Michael O'Riordan

April 07, 2024

News Conference News ACC 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Shelley Wood

April 06, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Conference News ACC 2023

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

L.A. McKeown

March 14, 2023

News Conference News ACC 2023

UK Mini Mitral: No Clear Win for Minimally Invasive MV Repair

Todd Neale

March 13, 2023

News Conference News ACC 2023

Wearable Device Helps HF Patients Avoid Coming Back to the Hospital: BMAD

Caitlin E. Cox

March 06, 2023

News Conference News ACC 2023

Too Many HF Patients Exiting Rural Hospitals Miss Out on Endorsed Therapies

Caitlin E. Cox

February 23, 2023

News Conference News ACC 2022

Global STEMI Outcomes May Improve With Tracking, GHATI Hints

Shelley Wood

April 11, 2022

News Conference News ACC 2022

QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis

L.A. McKeown

April 07, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

News Conference News ACC 2022

Bystander CPR for Cardiac Arrest Woefully Rare in Black and Hispanic Individuals

L.A. McKeown

March 24, 2022

News Conference News ACC 2021

Global STEMI Initiative Helps Low- and Middle-Income Countries Achieve Better Metrics

L.A. McKeown

May 24, 2021

News Conference News ACC 2021

ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19

Todd Neale

May 17, 2021

Presentation ACC 2021

Effect of a Hospital and Post-discharge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction

Presenter: Adam DeVore

May 17, 2021

News Conference News ACC 2021

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

Caitlin E. Cox

May 16, 2021

News Conference News ACC 2021

Use of a Rapid, High-Sensitivity Troponin Protocol Doesn’t Boost 1-Year Outcomes

Todd Neale

May 16, 2021

News Conference News ACC 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Shelley Wood

May 16, 2021

Advertisement

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Telemedicine Strategy After MI Scores a Win in TELE-ACS

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

UK Mini Mitral: No Clear Win for Minimally Invasive MV Repair

Wearable Device Helps HF Patients Avoid Coming Back to the Hospital: BMAD

Too Many HF Patients Exiting Rural Hospitals Miss Out on Endorsed Therapies

Global STEMI Outcomes May Improve With Tracking, GHATI Hints

QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Bystander CPR for Cardiac Arrest Woefully Rare in Black and Hispanic Individuals

Global STEMI Initiative Helps Low- and Middle-Income Countries Achieve Better Metrics

ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19

Effect of a Hospital and Post-discharge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

Use of a Rapid, High-Sensitivity Troponin Protocol Doesn’t Boost 1-Year Outcomes

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content